BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28641978)

  • 1. ANGPTL4 T266M variant is associated with reduced cancer invasiveness.
    Tan ZW; Teo Z; Tan C; Choo CC; Loo WS; Song Y; Tam ZY; Ng SP; Koh HZ; Ng YS; Shochat SG; Yau YH; Zhu P; Tan NS
    Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1525-1536. PubMed ID: 28641978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANGPTL4 modulates vascular junction integrity by integrin signaling and disruption of intercellular VE-cadherin and claudin-5 clusters.
    Huang RL; Teo Z; Chong HC; Zhu P; Tan MJ; Tan CK; Lam CR; Sng MK; Leong DT; Tan SM; Kersten S; Ding JL; Li HY; Tan NS
    Blood; 2011 Oct; 118(14):3990-4002. PubMed ID: 21841165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
    Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
    Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced ANGPTL4 sustains tumour growth and anoikis resistance through different mechanisms in scirrhous gastric cancer cell lines.
    Baba K; Kitajima Y; Miyake S; Nakamura J; Wakiyama K; Sato H; Okuyama K; Kitagawa H; Tanaka T; Hiraki M; Yanagihara K; Noshiro H
    Sci Rep; 2017 Sep; 7(1):11127. PubMed ID: 28894280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of angiopoietin-like 4 inhibits the development of human gastric cancer.
    Chen JW; Luo YJ; Yang ZF; Wen LQ; Huang L
    Oncol Rep; 2018 Apr; 39(4):1739-1746. PubMed ID: 29436683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of adenylate energy charge by angiopoietin-like 4 enhances epithelial-mesenchymal transition by inducing 14-3-3γ expression.
    Teo Z; Sng MK; Chan JSK; Lim MMK; Li Y; Li L; Phua T; Lee JYH; Tan ZW; Zhu P; Tan NS
    Oncogene; 2017 Nov; 36(46):6408-6419. PubMed ID: 28745316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LMX1A inhibits C-Myc expression through ANGPTL4 to exert tumor suppressive role in gastric cancer.
    Qian P; Li J; Zhang X; Li F; Bei S; Li H; Sun Q; Feng L
    PLoS One; 2019; 14(9):e0221640. PubMed ID: 31557193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T266M variants of ANGPTL4 improve lipid metabolism by modifying their binding affinity to acetyl-CoA carboxylase in obstructive sleep apnea.
    Li X; Li C; Xue W; Wei Z; Shen H; Wu K; Zhu H; Xu H; Wu X; Yi H; Guan J; Yin S
    Ann Med; 2024 Dec; 56(1):2337740. PubMed ID: 38574398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of angiopoietin-like 4 fibrinogen-like domain (cANGPTL4) increases risk of brain metastases in women with breast cancer.
    Dao T; Gapihan G; Leboeuf C; Hamdan D; Feugeas JP; Boudabous H; Zelek L; Miquel C; Tran T; Monnot C; Germain S; Janin A; Bousquet G
    Oncotarget; 2020 May; 11(18):1590-1602. PubMed ID: 32405335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
    Zhu X; Guo X; Wu S; Wei L
    Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced angiopoietin-like protein 4 as a clinical biomarker and treatment target for human prostate cancer.
    Hata S; Nomura T; Iwasaki K; Sato R; Yamasaki M; Sato F; Mimata H
    Oncol Rep; 2017 Jul; 38(1):120-128. PubMed ID: 28560449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition.
    Okamoto H; Cavino K; Na E; Krumm E; Kim S; Stevis PE; Harp J; Murphy AJ; Yancopoulos GD; Gromada J
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2747-2752. PubMed ID: 28143927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autophagy inhibition suppresses pulmonary metastasis of HCC in mice via impairing anoikis resistance and colonization of HCC cells.
    Peng YF; Shi YH; Ding ZB; Ke AW; Gu CY; Hui B; Zhou J; Qiu SJ; Dai Z; Fan J
    Autophagy; 2013 Dec; 9(12):2056-68. PubMed ID: 24157892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell.
    Fang KP; Dai W; Ren YH; Xu YC; Zhang SM; Qian YB
    BMC Cancer; 2016 Jan; 16():45. PubMed ID: 26822056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiopoietin-like 4 enhances metastasis and inhibits apoptosis via inducing bone morphogenetic protein 7 in colorectal cancer cells.
    Li X; Chen T; Shi Q; Li J; Cai S; Zhou P; Zhong Y; Yao L
    Biochem Biophys Res Commun; 2015 Nov; 467(1):128-34. PubMed ID: 26417691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of the c-Met proto-oncogene and Integrin α5β1 in human gastric cardia adenocarcinoma.
    Chi F; Fu D; Zhang X; Lv Z; Wang Z
    Biosci Biotechnol Biochem; 2012; 76(8):1471-6. PubMed ID: 22976495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANGPTL4 is a secreted tumor suppressor that inhibits angiogenesis.
    Okochi-Takada E; Hattori N; Tsukamoto T; Miyamoto K; Ando T; Ito S; Yamamura Y; Wakabayashi M; Nobeyama Y; Ushijima T
    Oncogene; 2014 Apr; 33(17):2273-8. PubMed ID: 23686315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis.
    Maric G; Annis MG; Dong Z; Rose AA; Ng S; Perkins D; MacDonald PA; Ouellet V; Russo C; Siegel PM
    Oncogene; 2015 Oct; 34(43):5494-504. PubMed ID: 25772243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiopoietin-like protein 4: A therapeutic target for triglycerides and coronary disease?
    Olshan DS; Rader DJ
    J Clin Lipidol; 2018; 12(3):583-587. PubMed ID: 29548670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.